StockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)

StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO) in a report released on Thursday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Price Performance

Shares of CO stock opened at $1.15 on Thursday. The stock has a market cap of $139.78 million, a PE ratio of 1.80 and a beta of 0.16. The business has a 50-day simple moving average of $1.02 and a 200-day simple moving average of $1.30. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.